Zdrowie i gospodarka · 16/03/2010

FDA Announces Public Meeting on Prescription Drug User Fee Act Reauthorization

The FDA is holding a public meeting to gather public input on the reauthorization of the Prescription Drug User Fee Act (PDUFA), which is set to expire in September 2012, and will require new legislation for FDA to continue collecting user fees for the prescription drug program.